Skip to main content
International Journal of Endocrinology logoLink to International Journal of Endocrinology
. 2017 May 3;2017:8165368. doi: 10.1155/2017/8165368

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”

Amilton Dos Santos-Júnior 1, Taciane Barbosa Henriques 2, Maricilda Palandi de Mello 2, Osmar Henrique Della Torre 1,*, Lúcia Arisaka Paes 1, Adriana Perez Ferreira-Neto 1, Letícia Esposito Sewaybricker 3, Thiago Salum Fontana 1, Eloisa Helena Rubello Valler Celeri 1, Gil Guerra-Júnior 3,4, Paulo Dalgalarrondo 1
PMCID: PMC5448052  PMID: 28592969

In the article titled “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents” [1], there was an error in the “Laboratory Evaluation” section, where the selected CYP2D6 SNP is written as rs72552269, and should be corrected to “rs1065852.”

References

  • 1.Santos-Júnior A. D., Henriques T. B., de Mello M. P., et al. Pharmacogenetics of risperidone and cardiovascular risk in children and adolescents. International Journal of Endocrinology. 2016;2016:10. doi: 10.1155/2016/5872423.5872423 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Endocrinology are provided here courtesy of Wiley

RESOURCES